• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC NEUROMODULATION VERCISE CARTESIA; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC NEUROMODULATION VERCISE CARTESIA; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS Back to Search Results
Model Number DB-2202-30
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Abscess (1690); Bacterial Infection (1735); Paralysis (1997); Confusion/ Disorientation (2553); No Code Available (3191)
Event Date 02/21/2020
Event Type  Injury  
Manufacturer Narrative
Additional suspect medical device components involved in the event: model: db-2202-30, serial/ lot: (b)(4), description: dbs directional lead sterile kit 30 cm.Model: nm-3138-55, serial/ lot: (b)(4), description: 55cm 8 contact extension model: nm-3138-55, serial/ lot: (b)(4), description: 55cm 8 contact extension.
 
Event Description
It was reported that nine days after the implant procedure, the patient experienced consciousness disorder and hemiplegia.A ct scan was performed, which showed an abscess on the right lead.The physician assessed that the patient had an infection with a cyst around the lead.A culture was performed and the results revealed that the patient had klebsiella oxytoca, staphylococcus capitis, and cutis propioni acnes.The patient was treated with antibiotics.The patient underwent a revision procedure and the entire system was explanted.All explanted devices were discarded by the facility.The patient was doing well postoperatively and had completely recovered.
 
Event Description
It was reported that nine days after the implant procedure, the patient experienced consciousness disorder and hemiplegia.A ct scan was performed, which showed an abscess on the right lead.The physician assessed that the patient had an infection with a cyst around the lead.A culture was performed and the results revealed that the patient had klebsiella oxytoca, staphylococcus capitis, and cutis propioni acnes.The patient was treated with antibiotics.The patient underwent a revision procedure and the entire system was explanted.All explanted devices were discarded by the facility.The patient was doing well postoperatively and had completely recovered.
 
Manufacturer Narrative
Correction to field a1: patient identifier.Correction to field e1: initial reporter phone.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VERCISE CARTESIA
Type of Device
STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS
Manufacturer (Section D)
BOSTON SCIENTIFIC NEUROMODULATION
25155 rye canyon loop
valencia CA 91355
MDR Report Key9968891
MDR Text Key188184837
Report Number3006630150-2020-01783
Device Sequence Number1
Product Code NHL
UDI-Device Identifier08714729905271
UDI-Public08714729905271
Combination Product (y/n)N
PMA/PMN Number
P150031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 08/31/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date10/29/2021
Device Model NumberDB-2202-30
Device Catalogue NumberDB-2202-30
Device Lot Number5180996
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 03/18/2020
Initial Date FDA Received04/16/2020
Supplement Dates Manufacturer Received08/30/2021
Supplement Dates FDA Received08/31/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-